Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
PRKCE 5581 INGENOL MEBUTATE CHEMBL1863513 activator TdgClinicalTrial, GuideToPharmacologyInteractions
PRKCE 5581 (7S)-HYDROXYL-STAUROSPORINE CHEMBL574737 inhibitor ChemblInteractions
PRKCE 5581 MEPROBAMATE CHEMBL979 activator TdgClinicalTrial, DrugBank, TTD
PRKCE 5581 CHELERYTHRINE CHEMBL13045 inhibitor GuideToPharmacologyInteractions
PRKCE 5581 SOTRASTAURIN CHEMBL565612 inhibitor GuideToPharmacologyInteractions, ChemblInteractions
PRKCE 5581 Y-27632 CHEMBL559147 inhibitor GuideToPharmacologyInteractions
PRKCE 5581 BRYOSTATIN CHEMBL449158 TdgClinicalTrial
PRKCE 5581 CEP-2563 CHEMBL3545332 inhibitor ChemblInteractions
PRKCE 5581 BALANOL CHEMBL60254 inhibitor GuideToPharmacologyInteractions
PRKCE 5581 GSK-690693 CHEMBL494089 inhibitor ChemblInteractions
PRKCE 5581 ENZASTAURIN CHEMBL300138 inhibitor MyCancerGenome
PRKCE 5581 QUERCETIN CHEMBL50 inhibitor MyCancerGenome
PRKCE 5581 CHEMBL1236539 CHEMBL1236539 inhibitor GuideToPharmacologyInteractions
PRKCE 5581 MIDOSTAURIN CHEMBL608533 inhibitor ChemblInteractions

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
PRKCE rs2278773 C perphenazine efficacy yes as measured by changes in PANSS-T (positive and negative syndrome scale total score), using a mixed model repeated measures approach. Examined 6789 SNPs - p-value of p< or equal to 5x10-4 was considered significant. It was unclear whether the allele was associated with an increased or decreased response to drug. Allele C is associated with response to perphenazine in people with Schizophrenia. 22920393 981238707
PRKCE rs6720975 T donepezil efficacy yes The study contained a discovery sample and a replication sample, and also did a meta-analysis of the two samples together. Response is defined as patients whose mini-mental state examination (MMSE) points increased, remained stable, or the change in MMSE points between baseline and end of follow-up (deltaMMSE) fell by 1 point or less. Non-responders were defined as worsening of >3 points on the MMSE. Patients had been treated with cholinesterase inhibitors for at least 6 months. The study also assessed the influence of the SNP on deltaMMSE. Please note alleles have been complemented to the plus chromosomal strand, and that this SNP did NOT reach genome-wide significance in any of the samples. Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C. 23374588 1183703663